Pancreatic adenocarcinoma presenting as biliary sepsis in a young female: a case report highlighting diagnostic challenges and management strategies
DOI:
https://doi.org/10.18203/2349-3933.ijam20254143Keywords:
Pancreatic cancer, Obstructive jaundice, Epidemiological screening in young age, ARDS, PTBD, MRCP, ERCPAbstract
Pancreatic malignancy is typically associated with advanced age, with the highest incidence occurring globally in the 6th to 7th decade of life and a higher prevalence in men than women. We present a case of pancreatic adenocarcinoma in a 19-year-old female who presented with obstructive jaundice complicated by biliary sepsis, septic shock, and severe acute respiratory distress syndrome (ARDS). Management involved initiating broad-spectrum antibiotics and performing percutaneous transhepatic biliary drainage (PTBD) for source control. With gradual improvement, she was weaned off vasopressor and ventilator support and subsequently extubated. Magnetic resonance cholangiopancreatography (MRCP) revealed an ulcer proliferative growth, prompting endoscopic retrograde cholangiopancreatography (ERCP) with biopsy, which confirmed moderately differentiated adenocarcinoma of the pancreas. Pancreatic cancer, particularly ductal carcinomas, are rare in younger individuals, often leading to underappreciation of their clinical features and treatment among physicians. This case emphasizes the importance of considering malignancy in young patients presenting with pancreatic biliary sepsis. High suspicion warrants MRCP, and if malignancy is suspected, ERCP with histopathology should be performed for early diagnosis and intervention to impede disease progression.
References
Sermonesi G, Rampini A, Convertini G, Bova R, Zanini N, Bertelli R, et al. Biliary Sepsis Due to Recurrent Acute Calculus Cholecystitis (ACC) in a High Surgical-Risk Elderly Patient: An Unexpected Complication. Pathogens. 2022;11:1423. DOI: https://doi.org/10.3390/pathogens11121423
Charles Charles Li. Sepsis and pancreatic cancer: Biliary stents a significant risk factor in patients undergoing chemotherapy. JCO. 2021;39:399-9. DOI: https://doi.org/10.1200/JCO.2021.39.3_suppl.399
Malvezzi M, Carioli G, Bertuccio P, Rosso T, Boffetta P, Levi F, et al. European cancer mortality predictions for the year 2016 with focus on leukaemias. Ann Oncol. 2016;27(4):725–31. DOI: https://doi.org/10.1093/annonc/mdw022
Bosetti C, Bertuccio P, Negri E, La Vecchia C, Zeegers MP, Boffetta P. Pancreatic cancer: overview of descriptive epidemiology. Mol Carcinog. 2012;51(1):3–13. DOI: https://doi.org/10.1002/mc.20785
Ilic I, Ilic M. International patterns in incidence and mortality trends of pancreatic cancer in the last three decades: a joinpoint regression analysis. World J Gastroenterol. 2022;28:4698–715. DOI: https://doi.org/10.3748/wjg.v28.i32.4698
NCDIR. Three-Year Report of Population Based Cancer Registries 2012-2014, Incidence, Distribution, Trends in Incidence Rates and Projections of Burden of Cancer (Report of 27 PBCRs in India), NCDIR-NCRP, ICMR. 2016.
Luo D, Li Y, Yu X, Ji L, Gong X. Early- onset pancreatic cancer: A review. Transl Oncol. 2025;52:102239. DOI: https://doi.org/10.1016/j.tranon.2024.102239
Rawla P, Sunkara T, Thandra KC, Raj JP. Epidemiology of pancreatic cancer: Global trends, etiology and risk factors. World J Oncol. 2019;10(1):10-27. DOI: https://doi.org/10.14740/wjon1166
Chandana SR, Woods LM, Maxwell F, Gandolfo R, Bekaii-Saab T. Risk factors for early-onset pancreatic ductal adenocarcinoma: A systematic literature review. Eur J Cancer. 2024;198:113471. DOI: https://doi.org/10.1016/j.ejca.2023.113471
Abboud Y, Samaan JS, Oh J, Jiang Y, Randhawa N, Lew D, et al. Increasing pancreatic cancer incidence in young women in the United States: a population-based time-trend analysis, 2001–2018. Gastroenterology. 2023;164(6):978-89.6. DOI: https://doi.org/10.1053/j.gastro.2023.01.022
Li Y, Zhang X. Pancreatic cancer in young adults - an evolving entity? Am J Cancer Res. 2023;13(7):2763-72.
Ogobuiro I, Baca Y, Ribeiro JR, Walker P, Wilson GC, Gulhati P, et al. Multiomic characterization reveals a distinct molecular landscape in young-onset pancreatic cancer. JCO Precision Oncol. 2023;7:e2300152. DOI: https://doi.org/10.1200/PO.23.00152